Sequence Listings – ST.26
Despite concerns expressed by IP practitioners and patent applicants, WIPO has implemented its the new standard on sequence listings (WIPO standard ST.26). It came into force on July 1, 2022, without a transition period.
The new standard differs considerably in its requirements (including the required information). The table below briefly compares the most relevant differences between ST.25 and ST.26.
- virus name
- synthetic construct
- unidentified
- virus name
- artificial sequence
unknown
- D-amino acids
- Linear portions of branched sequences
- Nucleotide analogs
- D-amino acids
- Linear portions of branched sequences
- Nucleotide analogs
< 4 specific defined AA
< 10 specific defined nucleotides
< 4 specific defined AA
< 10 specific defined nucleotides
Feature key + qualifier
Feature key only
It is a challenge to convert sequence listings previously filed under ST.25 into the newer ST.26. However, it is a great relief that the new WIPO software is much easier to handle and makes it easy to export and import for translational purposes. Thus, I trust that we will not only quickly get used to the new standard but may eventually come to love ST.26
If you have further questions: Here we are www.feuchaus-gallo.com
The complete information on the new standard for generating and filing sequence listings, as well as access to the WIPO software can be found here: